The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cytogenetic changes in renal cell carcinoma: Basis for sensitivity and resistance to everolimus.
Imogen Rose Caldwell
No relevant relationships to disclose
Paul Oei
No relevant relationships to disclose
Daniel Ng
No relevant relationships to disclose
Peter C.C. Fong
No relevant relationships to disclose
Reuben James Broom
No relevant relationships to disclose